Joseph Kerger

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Marie Marchand, Nicolas van Baren, P. Weynants et al. · International Journal of Cancer · 1999 · 786 citations

Life Sciences, Immunology, Oncology +17

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

R. Wendel Naumann, Antoine Hollebecque, Tim Meyer et al. · Journal of Clinical Oncology · 2019 · 435 citations

Medicine, Oncology, Pharmacotherapy +17

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 389 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Cancer and renal insufficiency results of the BIRMA study

Nicolas Janus, Vincent Launay‐Vacher, E. Byloos et al. · British Journal of Cancer · 2010 · 194 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool

Simon Van Belle, Robert Paridaens, Georges Evers et al. · Supportive Care in Cancer · 2004 · 189 citations

Nursing, Oncology, Cancer Screening +13